COMUNICADO: Galderma recibe la opinión positiva para la aprobación de EPIDUO® 0,3% / 2,5% en gel para el acné (y 2)

Publicado 28/09/2016 19:47:10CET

13. Bourdes, V. et al. Natural history of acne lesions and atrophic acne scars within a 6-month study period poster presented at: WCD 2015

14. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37.

15. Collier et al. The prevalence of acne in adults 20 years and older, American Academy of Dermatology, 2008

16. Dréno, B., Tan, J., Kang, S. et al. Dermatol Ther (Heidelb) (2016) 6: 207. doi:10.1007/s13555-016-0113-x

17. O'NEILL J. The review on antimicrobial resistance. Tackling drug-resistant infections globally: final report and recommendations may 2016

CONTACTO: Contacto: Yvan Deurbroeck, vicepresidente global deComunicaciones, Galderma International Mobile. Tel: +41792543824

Europa Press Comunicados Empresas